CONMED

Global Aging And Minimally Invasive Trends Will Empower Future Markets

AnalystHighTarget

Not Invested

Community Contributor

Published

05 May 25

Updated

07 May 25

AnalystHighTarget's Fair Value

US$80.00

41.9% undervalued

23 Jul

US$46.52

-26.1%

-1.4%

-26.1%

-1.4%

You can edit this narrative until May 12 6:01 AM. Then, changes will post as Updates.

Author's Valuation

US$8041.9% undervalued

AnalystHighTarget Fair Value

Narrative

Updates1

Shared on07 May 25

AnalystHighTarget Fair Value

US$80

41.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

5.55%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.72%

Calculation

US$155.90m

Earnings '28

20.22x

PE Ratio '28

US$3.15b

Market Cap '28

US$3.15b

Market Cap '28

31.27m

No. shares '28

US$100.80

Share Price '28

US$100.80 Share Price '28

Discounted to 2025 @ 8.32% p.a.

US$79.30

Fair Value '25